| Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress R Burt, A Dey, S Aref, M Aguiar, A Akarca, K Bailey, W Day, S Hooper, ... Blood, The Journal of the American Society of Hematology 134 (17), 1415-1429, 2019 | 175 | 2019 |
| Walking to school: frequency and predictors among primary school children in Dunedin, New Zealand S Yelavich, C Towns, R Burt, K Chow, R Donohue, HSH Sani, K Taylor, ... The New Zealand Medical Journal (Online) 121 (1271), 2008 | 48 | 2008 |
| Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies R Burt, D Warcel, AK Fielding Human Vaccines & Immunotherapeutics 15 (3), 594-602, 2019 | 43 | 2019 |
| Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer V Harding, E Fenu, H Medani, R Shaboodien, S Ngan, HK Li, R Burt, ... British journal of cancer 107 (6), 925-930, 2012 | 40 | 2012 |
| Type 1 interferon responses underlie tumor-selective replication of oncolytic measles virus S Aref, AZ Castleton, K Bailey, R Burt, A Dey, D Leongamornlert, ... Molecular Therapy 28 (4), 1043-1055, 2020 | 23 | 2020 |
| Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1‐mutant acute myeloid leukaemia (AML) following reduced intensity chemotherapy … N Farah, R Burt, AR Ibrahim, R Baker, PD Kottaridis British Journal of Haematology 190 (4), e208, 2020 | 3 | 2020 |
| The Relevance of CD20 Targeting of Oncolytic Measles Virus in the Treatment of Adult Acute Lymphoblastic Leukemia KE Bailey, S Aref, A Dey, RJ Mitchell, RJ Burt, NJ Thomas, DASA Okasha, ... Blood 130, 3891, 2017 | 2 | 2017 |
| SCD inhibition preferentially eradicates AML displaying high de novo fatty acid desaturation and synergizes with chemotherapy V Dembitz, H Lawson, R Burt, C Philippe, SC James, S Atkinson, J Durko, ... bioRxiv, 2023.08. 02.551656, 2023 | 1 | 2023 |
| Inhibition of Stearoyl-CoA Desaturase Has Anti-Leukemic Properties in Acute Myeloid Leukemia V Dembitz, H Lawson, C Philippe, RJ Burt, S James, ASM Magee, ... Blood 140 (Supplement 1), 3058-3060, 2022 | 1 | 2022 |
| Concerns about how to use established minimal residual disease (MRD) monitoring in the treatment of NPM1-mutant AML following reduced intensity chemotherapy protocols for AML … N Farah, R Burt, AR Ibrahim, R Baker, PD Kottaridis British Journal of Haematology, 2020 | 1 | 2020 |
| Acute lymphoblastic leukaemia (ALL) cells and commonly-used chemotherapy drugs can induce bone marrow-derived mesenchymal stromal cells to become cancer associated fibroblasts … RJ Burt, A Dey, KCY Ng, B Liu, T Marafioti, E Sahai, AK Fielding Blood 130, 1165, 2017 | 1 | 2017 |
| Mitochondrial dsRNA from B-Precursor Acute Lymphoblastic Leukemia Cells Induce Formation of Cancer Associated Fibroblast in the Bone Marrow Leading to Formation of a … A Dey, R Burt, EA Cutler, HE Allen, J Chatzigerou, R Amerikanou, ... Blood 142, 4073, 2023 | | 2023 |
| Mitochondrial dsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer associated fibroblasts RJ Burt, A Dey, A Akarca, H Allen, R Amerikanou, S Atkinson, D Auty, ... bioRxiv, 2023.09. 26.559490, 2023 | | 2023 |
| The Role of Mitochondrial RNA from B-Precursor Acute Lymphoblastic Leukaemia Cells in Generating a Chemoprotective Bone Marrow Niche A Dey, RJ Burt, EA Cutler, HE Allen, A Dhir, K Kirschner, AK Fielding Blood 140 (Supplement 1), 2895-2896, 2022 | | 2022 |
| Defining the role of mesenchymal stromal cells in treatment resistance in acute lymphoblastic leukaemia RJ Burt UCL (University College London), 2020 | | 2020 |
| Commonly Used Chemotherapy Drugs Differentially Determine Microenvironment-Mediated Protection, Via Mitochondrial Transfer, to B-Precursor Acute Lymphoblastic Leukaemia Cells RJ Burt, A Dey, KCY Ng, E Sahai, AK Fielding Blood 132, 2690, 2018 | | 2018 |
| Oncolytic Measles Virus Replication is Enhanced in Acute Lymphoblastic Leukaemia-Associated Mesenchymal Stromal Cells Which Have Adopted a Cancer Associated Fibroblast … AD Dey, R Burt, S Aref, K Bailey, AK Fielding MOLECULAR THERAPY 26 (5), 9-9, 2018 | | 2018 |
| CD20 Targeting of Oncolytic Measles Virus in the Treatment of Adult Acute Lymphoblastic Leukemia K Bailey, S Aref, R Mitchell, KZ Alapi, M Aguiar, A Dey, R Burt, S Lee, ... MOLECULAR THERAPY 26 (5), 346-346, 2018 | | 2018 |
| Investigating the Bioenergetic and Metabolic Effects of Oncolytic Measles Virus in a Stromal Model of Cellular Transformation S Aref, A Sheppard, R Burt, K Bailey, A Dey, G Szabadkai, AK Fielding MOLECULAR THERAPY 26 (5), 345-345, 2018 | | 2018 |
| IFITM1 Plays an Important Role in Determining Resistance of Normal MSCs to Oncolytic Measles Virus S Aref, AZ Castleton, A Dey, K Bailey, R Burt, AK Fielding MOLECULAR THERAPY 26 (5), 202-203, 2018 | | 2018 |
